US bank card large Visa started improvement exercise in Israel this week, after shopping for Israeli startup BioCatch, its second-ever acquisition in Israel. The veteran cybersecurity firm based in 2011 is seen as one of the crucial vital safety suppliers to massive banks within the US and Western international locations.
The acquisition displays a pointy enhance within the valuation of the Israeli firm in simply two years: In 2024, 57% of its shares had been bought to personal fairness fund Permira, which is managed in Israel by Ran Maidan, at an organization valuation of $1.3 billion, whereas this week the valuation by Visa soared to $2.4 billion by Visa, making it certainly one of Permira’s quickest and most profitable exits in Israel.
Many of the Israeli buyers within the fund, together with early buyers reminiscent of David Assia, Janvest and Jouie Ventures had already bought their shares in it. On the time of the sale on Monday, the corporate was backed primarily by international buyers, the principle ones being US non-public fairness funds reminiscent of Permira, Sapphire and Macquarie, in addition to enterprise capital funds reminiscent of Maverick, Blumberg Capital and American Categorical. Nonetheless, Jerusalem-based investor group OurCrowd, which was one of many firm’s first buyers, is coming away with a big revenue from the deal and is being handsomely rewarded for the shut relationship maintained with BioCatch since 2015.
Desires certified buyers
Estimates are that OurCrowd acquired about $200 million in money from the sale of shares within the varied rounds, of which about $100 million was on this week’s sale, “Globes” discovered. OurCrowd declined to substantiate the main points.
That is probably essentially the most vital ever exit for OurCrowd, the Jerusalem-based investor group, which has a enterprise mannequin that differs from common enterprise capital funds and has been criticized previously by conventional enterprise capital buyers. The group was based over 15 years in the past by chairman John Medved (who retired from the place of CEO on the finish of 2025 and was changed by Cali Chill), a former Jerusalem enterprise capitalist, who arrange a community that brings collectively 1000’s of certified buyers for fundraising rounds when alternatives come up.
Thus, as an alternative of counting on a small variety of institutional anchor buyers who will make investments many thousands and thousands of {dollars}, however can even dictate the phrases of the fund to the administration, as in different enterprise capital funds, OurCrowd operates in the wrong way: it identifies funding alternatives in tech firms after which recruits certified buyers who can take part within the funding – even for a comparatively small quantity, reminiscent of ten thousand {dollars} – by its web site.
RELATED ARTICLES
Visa buys Israeli fraud prevention co BioCatch for $2.4b
In accordance with estimates by senior figures within the enterprise capital business, whereas the sale to Permira mirrored a mean return of 7-8 occasions on the funding for OurCrowd, some certified buyers could have earned twenty occasions their funding within the new deal. The profile of certified buyers modifications with every spherical, as does the worth of the corporate at which the funding is being made.
In recent times, OurCrowd has modified the character of its actions. Up to now, it was essentially the most energetic investor in early stage startups, however lately it has centered on investing in additional mature firms and has additionally recruited institutional buyers reminiscent of Japanese telecommunications firm NTT and Swedish truck producer Scania. The fund additionally finds buyers who’re making ready to spend money on superior rounds in tech firms which might be already in a complicated gross sales stage. One among them is Anthropic, during which OurCrowd purchased shares in an early-stage spherical in 2024, when the worth of the AI large was solely $17 billion. The worth of its holdings, that are made in partnership with many different buyers (SPV), has elevated over 50-fold, with Anthropic aiming for an IPO at a price of virtually $1 trillion.
No response has been forthcoming from BioCatch and OurCrowd.
Revealed by Globes, Israel enterprise information – en.globes.co.il – on August 6, 2026.
© Copyright of Globes Writer Itonut (1983) Ltd., 2026.
